Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.4750 (-0.46%) ($6.4750 - $6.4750) on Mon. May. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.12% (three month average) | RSI | 50 | Latest Price | $6.4750(-0.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.2% a day on average for past five trading days. | Weekly Trend | TGTX declines -5.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(75%) ARKG(71%) IBB(68%) ARKK(65%) IBUY(59%) | Factors Impacting TGTX price | TGTX will decline at least -3.06% in a week (0% probabilities). VIXM(-55%) VXX(-39%) UUP(-19%) TBT(-10%) USO(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.06% (StdDev 6.12%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.82(-236.22%) | Resistance Level | $6.92 | 5 Day Moving Average | $6.23(3.93%) | 10 Day Moving Average | $6.72(-3.65%) | 20 Day Moving Average | $6.92(-6.43%) | To recent high | -42.7% | To recent low | 13.7% | Market Cap | $820m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |